Puma Biotechnology, Inc.PBYINASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank21
3Y CAGR-36.1%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-36.1%/yr
vs -21.0%/yr prior
Acceleration
-15.0pp
Decelerating
Percentile
P21
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20252.28+41.7%
20241.61-57.8%
20233.82-56.3%
20228.75+117.3%
2021-50.51+26.0%
2020-68.23-451.3%
201919.43-13.7%
201822.51-67.4%
201768.93+1314.9%
20164.87-